Back

Cardiac amyloidosis in iceland: a nationwide epidemiologic study.

11 May 2024 (15:00 - 15:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - epidemiology, prognosis, outcome 9 Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Miss Helena Johannsdottir

Landspitali University Hospital, Reykjavik (Iceland)

5 More presentations in this session

Presentation thumbnail
Impact of cardiac biomarkers on heart failure risk prediction in the general population
Doctor C. Morbach (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Higher red blood cell distribution width is associated with worse outcomes in patients with chronic heart failure
Doctor L. Sensini (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Predicting mortality in chronic heart failure: combined evaluation of VE/VCO2 and pVO2 independent of LVEF
Doctor J. Westphal (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Impact of insulin therapy in diabetic patients hospitalized with acute heart failure
Doctor F. Bahouth (Nazareth, IL)
Abstract Slides Video
Presentation thumbnail
I NEED HELP: unleashing the full potential of the acronym for the management of patients with heart failure and reduced ejection fraction
Doctor M. Paiva (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - epidemiology, prognosis, outcome 9

The Event

Event poster

Heart Failure 2024

11 May 2024 15:00 CET
You may be interested in
thumbnail
Congress Session
Transthyretin cardiac amyloidosis
thumbnail
Congress Session
Cardiac amyloidosis from epidemiology to treatment
thumbnail
Congress Session
Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources